Coronary Heart Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years old; 2. Cognitive and information acceptance ability: a. Able to communicate normally; Be able to read and understand the informed consent form independently or with the simple assistance of researchers, and sign it voluntarily; b. Own and skillfully use smart phones (wechat and other common apps), and be able to receive, read and understand text messages. 3. Residence and Language: live in the current community for a long time, be able to communicate effectively in Mandarin or local dialect, and promise no long-term relocation plan in the next 6 months. 4. Compliance with device use: Agree and promise to wear ActiGraph wGT3X-BT accelerometer for physical activity monitoring as required during the study. 5. Disease diagnosis: one of the following conditions is confirmed by secondary and tertiary hospitals: a. Stable coronary artery disease: including previous myocardial infarction history (>6 months), percutaneous coronary intervention (>6 months), coronary artery bypass grafting (>6 months); b. Stable heart failure: New York Heart Association class I or II ; c. Essential hypertension: Currently well-controlled blood pressure: blood pressure measured at screening while sitting at rest < 130/80mmHg. 6. Stable condition: no hospitalization due to acute cardiovascular disease in the past 6 months.
Exclusion criteria
Exclusion criteria: 1. Severe limitation of mobility: severe orthopedic, neurological or other system diseases (such as advanced arthritis, Parkinson's disease, severe emphysema, etc.), resulting in inability to walk independently. 2. Increased frequency or severity of angina pectoris in the past week; Chest pain, dyspnea, dizziness, palpitation and other symptoms occurred in the resting state or after mild daily activities (such as dressing and walking slowly). 3. Expected poor adherence: history of alcohol or substance abuse. 4. History of malignant arrhythmia within the past 6 months. Ejection Fraction (EF) < 50%. 6. Other contraindications: the presence of severe valvular disease, pulmonary hypertension, aortic aneurysm, acute myocarditis and other absolute contraindications to exercise. 7. Participating in other intervention studies: Currently participating in other physical activity or other cardiovascular health related clinical intervention trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Daily Step Count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Daily Moderate-to-Vigorous Physical Activity (MVPA) Time;Acceptability and Feasibility of the Intervention;Systolic and Diastolic Blood Pressure;Body Weight; | — |
Countries
China
Contacts
The First Affiliated Hospital of Kunming Medical University